Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 29 to Dec. 3, 2021. […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Nov. 29 to Dec. 3, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Odds of SARS-CoV-2 Infection Down After Third BNT162b2 Dose
FRIDAY, Dec. 3, 2021 (HealthDay News) — Receipt of a third booster BNT162b2 dose is associated with a reduction in the odds of testing positive for severe acute respiratory syndrome coronavirus 2, according to a study published online Nov. 30 in JAMA Internal Medicine.
One in Five Adults May Have Avoided Health Care During the Pandemic
FRIDAY, Dec. 3, 2021 (HealthDay News) — One in five individuals avoided health care during COVID-19 lockdowns, often for potentially urgent symptoms, according to a Dutch study published online Nov. 23 in PLOS Medicine.
Omicron Variant May Overcome Prior COVID-19 Infection
FRIDAY, Dec. 3, 2021 (HealthDay News) — People who have already had COVID-19 have a higher risk of reinfection with the omicron coronavirus variant than with earlier variants, new research shows. The South African scientists who reported the findings believe that vaccination will have the power to stop severe illness, however.
Most Vaccinated Adults Plan to Get Boosters: Poll
FRIDAY, Dec. 3, 2021 (HealthDay News) — Most vaccinated American adults have every intention of getting booster shots, a new poll finds.
New York Reports Five Omicron Cases, U.S. Total Rises to Nine
FRIDAY, Dec. 3, 2021 (HealthDay News) — Five cases of the omicron coronavirus variant have been detected in New York state, one in Minnesota, and one in Hawaii, officials in those states announced Thursday. That brings the known total in the United States to nine, with California and Colorado previously announcing one case each.
mRNA-1273 Has High Vaccine Effectiveness After Five Months
FRIDAY, Dec. 3, 2021 (HealthDay News) — The vaccine effectiveness of two doses of Moderna mRNA-1273 is 87.4 percent against COVID-19 infection and 95.8 and 97.9 percent against COVID-19 hospitalization and hospital death, respectively, according to a study published online Nov. 25 in The Lancet Regional Health: Americas.
COVID-19 Hospital Admission Up for Children With Uncontrolled Asthma
FRIDAY, Dec. 3, 2021 (HealthDay News) — School-aged children with uncontrolled asthma have increased risk of COVID-19 hospital admission, according to a study published online Nov. 30 in The Lancet Respiratory Medicine.
Care for Eating Disorders Up During Pandemic
THURSDAY, Dec. 2, 2021 (HealthDay News) — The number of patients receiving inpatient or outpatient care for eating disorders has increased during the COVID-19 pandemic, according to a research letter published online Nov. 16 in JAMA Network Open.
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
Most U.S. Adults Unsure Which Vaccines CDC Recommends During Pregnancy .jpg)
Pregnancy Complications Rare for Women Receiving CAR T-Cell Therapy 
Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
